This retrospective analysis (n=171) examined the effectiveness of esketamine in participants with treatment-resistant depression (TRD). A significant reduction in depressive symptoms was observed using the PHQ-9 and GAD-7 from baseline to last the last treatment.
- Published
- Journal
- Future Medicine
- Authors
- Brendle, M., Ahuja, S., Della Valle, M., Moore, C., Thielking, P., Malone, D. C., Robison, R.